beta
IBER=
Ibere Pharmaceuticals
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Ibere Pharmaceuticals is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Although the Company may pursue an acquisition opportunity in any business or industry, it intends to focus on opportunities in the pharmaceutical and life sciences industries.
Market Cap: 141 Million
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Shares Outstanding: 13.8 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector:
Industry:
Ethical Flags
Longest drawdown: 380 trading days
From: 2022-01-07 To: 2023-02-06
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|